244 related articles for article (PubMed ID: 14617629)
1. S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE).
Arumugam T; Simeone DM; Schmidt AM; Logsdon CD
J Biol Chem; 2004 Feb; 279(7):5059-65. PubMed ID: 14617629
[TBL] [Abstract][Full Text] [Related]
2. S100P promotes pancreatic cancer growth, survival, and invasion.
Arumugam T; Simeone DM; Van Golen K; Logsdon CD
Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848
[TBL] [Abstract][Full Text] [Related]
3. RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways.
Fuentes MK; Nigavekar SS; Arumugam T; Logsdon CD; Schmidt AM; Park JC; Huang EH
Dis Colon Rectum; 2007 Aug; 50(8):1230-40. PubMed ID: 17587138
[TBL] [Abstract][Full Text] [Related]
4. Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models.
Arumugam T; Ramachandran V; Logsdon CD
J Natl Cancer Inst; 2006 Dec; 98(24):1806-18. PubMed ID: 17179482
[TBL] [Abstract][Full Text] [Related]
5. S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancer.
Onyeagucha BC; Mercado-Pimentel ME; Hutchison J; Flemington EK; Nelson MA
Exp Cell Res; 2013 Aug; 319(13):2081-2090. PubMed ID: 23693020
[TBL] [Abstract][Full Text] [Related]
6. S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis.
Arumugam T; Ramachandran V; Gomez SB; Schmidt AM; Logsdon CD
Clin Cancer Res; 2012 Aug; 18(16):4356-64. PubMed ID: 22718861
[TBL] [Abstract][Full Text] [Related]
7. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains.
Leclerc E; Fritz G; Weibel M; Heizmann CW; Galichet A
J Biol Chem; 2007 Oct; 282(43):31317-31. PubMed ID: 17726019
[TBL] [Abstract][Full Text] [Related]
8. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo.
Riuzzi F; Sorci G; Donato R
J Biol Chem; 2006 Mar; 281(12):8242-53. PubMed ID: 16407300
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of receptor for advanced glycation end products induces monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cell line.
Hayakawa E; Yoshimoto T; Sekizawa N; Sugiyama T; Hirata Y
J Atheroscler Thromb; 2012; 19(1):13-22. PubMed ID: 22082983
[TBL] [Abstract][Full Text] [Related]
10. S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE).
Jin Q; Chen H; Luo A; Ding F; Liu Z
PLoS One; 2011 Apr; 6(4):e19375. PubMed ID: 21559403
[TBL] [Abstract][Full Text] [Related]
11. The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells.
Mercado-Pimentel ME; Onyeagucha BC; Li Q; Pimentel AC; Jandova J; Nelson MA
FEBS Lett; 2015 Aug; 589(18):2388-93. PubMed ID: 26193421
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of S100P, receptor for advanced glycation end products and ezrin in malignant melanoma.
Zhu L; Ito T; Nakahara T; Nagae K; Fuyuno Y; Nakao M; Akahoshi M; Nakagawa R; Tu Y; Uchi H; Furue M
J Dermatol; 2013 Dec; 40(12):973-9. PubMed ID: 24303922
[TBL] [Abstract][Full Text] [Related]
13. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways.
Huttunen HJ; Fages C; Rauvala H
J Biol Chem; 1999 Jul; 274(28):19919-24. PubMed ID: 10391939
[TBL] [Abstract][Full Text] [Related]
14. Structural insights into calcium-bound S100P and the V domain of the RAGE complex.
Penumutchu SR; Chou RH; Yu C
PLoS One; 2014; 9(8):e103947. PubMed ID: 25084534
[TBL] [Abstract][Full Text] [Related]
15. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation.
Huttunen HJ; Kuja-Panula J; Sorci G; Agneletti AL; Donato R; Rauvala H
J Biol Chem; 2000 Dec; 275(51):40096-105. PubMed ID: 11007787
[TBL] [Abstract][Full Text] [Related]
16. Differential effects between amphoterin and advanced glycation end products on colon cancer cells.
Kuniyasu H; Chihara Y; Kondo H
Int J Cancer; 2003 May; 104(6):722-7. PubMed ID: 12640679
[TBL] [Abstract][Full Text] [Related]
17. Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion.
Yeh CH; Sturgis L; Haidacher J; Zhang XN; Sherwood SJ; Bjercke RJ; Juhasz O; Crow MT; Tilton RG; Denner L
Diabetes; 2001 Jun; 50(6):1495-504. PubMed ID: 11375353
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end-products (AGEs) induce concerted changes in the osteoblastic expression of their receptor RAGE and in the activation of extracellular signal-regulated kinases (ERK).
Cortizo AM; Lettieri MG; Barrio DA; Mercer N; Etcheverry SB; McCarthy AD
Mol Cell Biochem; 2003 Aug; 250(1-2):1-10. PubMed ID: 12962137
[TBL] [Abstract][Full Text] [Related]
19. Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation.
Huttunen HJ; Kuja-Panula J; Rauvala H
J Biol Chem; 2002 Oct; 277(41):38635-46. PubMed ID: 12167613
[TBL] [Abstract][Full Text] [Related]
20. S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells.
Hsieh HL; Schäfer BW; Weigle B; Heizmann CW
Biochem Biophys Res Commun; 2004 Apr; 316(3):949-59. PubMed ID: 15033494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
